Rocket One (RKTO) Operating Expenses (2018 - 2026)
Rocket One's (RKTO) quarterly Operating Expenses came in at $3.8 million in Q2 2026, up 74.34% year-over-year from $2.2 million in Q2 2025, and up 44.79% quarter-over-quarter from $2.6 million in Q1 2026.
Analysis
Rocket One (RKTO) Operating Expenses (2018 - 2026) Analysis & Trends
Rocket One has disclosed Operating Expenses across 9 years of filings, most recently posting $3.8 million for Q2 2026.
- In Q2 2026, Operating Expenses rose 74.34% year-over-year to $3.8 million; the TTM figure through Jun 2026 stood at $13.2 million (up 31.59% YoY), while the FY2025 annual figure was $12.4 million, up 50.46% from the prior year.
- Operating Expenses came in at $3.8 million for Q2 2026 at Rocket One, up from $2.6 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $4.1 million in Q3 2025 to a low of $1.7 million in Q2 2024.
- Average Operating Expenses over 5 years is $2.6 million, with a median of $2.3 million recorded in 2022.
- Year-over-year, Operating Expenses slumped 47.6% in 2023 and surged 83.05% in 2025.
- Over 5 years, Operating Expenses stood at $3.4 million in 2022, then tumbled by 47.6% to $1.8 million in 2023, then grew by 17.32% to $2.1 million in 2024, then rose by 23.88% to $2.6 million in 2025, then jumped by 47.21% to $3.8 million in 2026.
- Per Business Quant data, the three most recent Operating Expenses figures were $3.8 million in Q2 2026, $2.6 million in Q1 2026, and $2.6 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 212.04 Bn | 198.05 Bn | 7.24 Bn | 6.54 Bn |
| 2 | Gilead Sciences | 181.35 Bn | 178.17 Bn | 6.22 Bn | 18.20 Bn |
| 3 | Vertex Pharmaceuticals | 132.22 Bn | 124.37 Bn | 2.84 Bn | 2.09 Bn |
| 4 | Regeneron Pharmaceuticals | 82.94 Bn | 74.94 Bn | 3.93 Bn | 3.00 Bn |
| 5 | Argenx Se | 61.53 Bn | 56.34 Bn | 1.37 Bn | -1.05 Bn |
| 6 | Moderna | 54.25 Bn | 49.11 Bn | 52.00 Mn | 960.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.41 Bn | 31.10 Bn | 992.69 Mn | 1.06 Bn |
| 8 | Biogen | 31.19 Bn | 29.91 Bn | 1.96 Bn | 2.60 Bn |
| 9 | Roivant Sciences | 30.10 Bn | 30.10 Bn | 1.16 Mn | 367.83 Mn |
| 10 | Rocket One | 13.87 Mn | 5.98 Mn | - | 3.83 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.83 Mn |
| Mar 31, 2026 | 2.65 Mn |
| Dec 31, 2025 | 2.61 Mn |
| Sep 30, 2025 | 4.08 Mn |
| Jun 30, 2025 | 2.20 Mn |
| Mar 31, 2025 | 3.48 Mn |
| Dec 31, 2024 | 2.10 Mn |
| Sep 30, 2024 | 2.23 Mn |
| Jun 30, 2024 | 1.72 Mn |
| Mar 31, 2024 | 2.16 Mn |
| Dec 31, 2023 | 1.79 Mn |
| Sep 30, 2023 | 2.18 Mn |
| Jun 30, 2023 | 1.73 Mn |
| Mar 31, 2023 | 2.24 Mn |
| Dec 31, 2022 | 3.42 Mn |
| Sep 30, 2022 | 2.68 Mn |
| Jun 30, 2022 | 2.30 Mn |
| Mar 31, 2022 | 2.66 Mn |
| Dec 31, 2021 | 3.38 Mn |
| Sep 30, 2021 | 3.25 Mn |